Who is sponsoring NCT04460976?

NCT04460976 is sponsored by Karolinska Institutet.

What condition does NCT04460976 study?

NCT04460976 studies Treatment Satisfaction, Knowledge Acquisition Disability Nos, Anxiety, Depression, Quality of Life, Relation, Family, Acceptance of Diagnosis, Stigma of Mental Illness, Participation.

Is NCT04460976 still recruiting?

NCT04460976 is currently completed. Last updated 14 December 2020.

Last reviewed 2020-12-14 · How we verify

NCT04460976: Prisma

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Psychoeducation for Adults With Autism and Their Significant Others/Family Members

Completed NA Last updated 14 December 2020

What this trial tests

NA trial testing Psychoeducation for Adults With Autism and Their Significant Others/Family members (Prisma) in Treatment Satisfaction in 718 participants. Completed in 15 September 2020.

Timeline

1 September 2017

Primary endpoint
15 September 2020

15 September 2020

Quick facts

Lead sponsor	Karolinska Institutet
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	718
Start date	1 September 2017
Primary completion	15 September 2020
Estimated completion	15 September 2020
Sites	1 location across Sweden

Drugs / interventions tested

Psychoeducation for Adults With Autism and Their Significant Others/Family members (Prisma)
Treatment as usual/standard care

Conditions studied

Treatment Satisfaction — all drugs for Treatment Satisfaction →
Knowledge Acquisition Disability Nos — all drugs for Knowledge Acquisition Disability Nos →
Anxiety — all drugs for Anxiety →
Depression — all drugs for Depression →

Sponsor

Karolinska Institutet

Who can join

18 and older, any sex, with Treatment Satisfaction or Knowledge Acquisition Disability Nos. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prisma is a four-session psychoeducational intervention administered in groups for individuals with ASD together with their family members and significant others. The aspiration is to make Prisma into an affordable, accessible and available intervention. This includes taking into account a great age spectrum, differences in comorbidity as well as other varied qualities that characterize this group. Acknowledging this diversity and helping to create opportunity for these individuals is of great importance in order to follow national as well as international legislations of the patient's rights. The aim of the proposed studies is to evaluate the feasibility and effect of Prisma in adults (18 or over) with ASD and their family members/significant others in an outpatient clinical habilitation context.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Psychoeducational group intervention for intellectually able adults with autism and their close relations (Prisma) - an open feasibility study.
Hidalgo N, Sjöwall D, Agius H, Byström C, et al · · 2022 · cited 5× · PMID 35986348 · DOI 10.1186/s12888-022-04134-4
Psychoeducational Group Intervention for Adults with Autism Spectrum Disorder and Their Close Relations (Prisma) – An Open Feasibility Study
Hidalgo N, Sjöwall D, Agius H, Byström C, et al · · 2021 · DOI 10.21203/rs.3.rs-1121143/v1

Verify or expand the search:

Other Karolinska Institutet trials

Trials by the same sponsor.

NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04460976 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
Last refreshed: 14 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04460976.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing